| Literature DB >> 27826334 |
Ahmet Goktug Ertem1, Filiz Ozcelik1, Haci Ahmet Kasapkara2, Cemal Koseoglu1, Serdal Bastug1, Huseyin Ayhan2, Cenk Sari1, Nihal Akar Bayram2, Emine Bilen1, Tahir Durmaz2, Telat Keles2, Engin Bozkurt2.
Abstract
BACKGROUND AND OBJECTIVES: In this study, we examined the role of inflammatory parameters in an apical mural thrombus with a reduced ejection fraction due to large anterior myocardial infarction (MI). SUBJECTS AND METHODS: A total of 103 patients who had suffered from heart failure, 45 of whom had left ventricular apical thrombus (AT) after a large anterior MI, were enrolled in the study. A detailed clinical history was taken of each participant, biochemical inflammatory markers, which were obtained during admission, were analyzed and an echocardiographical and angiographical evaluation of specific parameters were performed.Entities:
Keywords: Inflammation; Myocardial infarction; Thrombus
Year: 2016 PMID: 27826334 PMCID: PMC5099331 DOI: 10.4070/kcj.2016.46.6.768
Source DB: PubMed Journal: Korean Circ J ISSN: 1738-5520 Impact factor: 3.243
Demographical, echocardiographical and angiographical characteristics of study subjects and controls
| Variables | Thrombus (+) patients (n=45) | Thrombus (−) patients (n=58) | p |
|---|---|---|---|
| Gender (female) (n, %) | 8 (17) | 12 (20.6) | 0.734 |
| Age (years±SD) | 62.52±13.56 | 61.49±7.88 | 0.803 |
| Diabetes mellitus (n, %) | 15 (33) | 10 (17) | 0.342 |
| Hypertension (n, %) | 34 (75) | 21 (36) | 0.125 |
| Coronary heart disease (n, %) | 41 (91) | 58 (100) | 0.089 |
| PCI (n, %) | 26 (57) | 32 (55) | 0.812 |
| CABG (n, %) | 14 (31) | 23 (39) | 0.351 |
| Atrial fibrillation (n, %) | 2 (0.4) | 1 (0.1) | 0.341 |
| Heart failure (n, %) | 45 (100) | 58 (100) | 1 |
| Smoking (n, %) | 34 (75) | 28 (48) | 0.029 |
| ACE blokers (n, %) | 45 (100) | 58 (100) | 1 |
| Aldosterone ant. (n, %) | 45 (100) | 58 (100) | 1 |
| Beta bloker (n, %) | 45 (100) | 58 (100) | 1 |
| Antiplatelet agents (n, %) | 45 (100) | 58 (100) | 1 |
| Anticoagulant (n, %) | 2 (0.2) | 1 (0.1) | 0.560 |
| Diuretics (loop diuretic) (n, %) | 45 (100) | 58 (100) | 1 |
| LV end diastolic diameter (cm±SD) | 5.59±0.89 | 5.57±0.88 | 0.540 |
| LV end systolic diameter (cm±SD) | 4.47±1.04 | 4.41±1.12 | 0.982 |
| LV ejection fraction (%±SD) | 28.63±11.69 | 29.19±12.16 | 0.822 |
| Left atrial diameter (cm±SD) | 4.49±0.78 | 4.28±0.47 | 0.220 |
| ECG changes for aneurysmal formation | 37 (82) | 45 (77) | 0.260 |
| LAD proksimal | 30 (66) | 25 (43) | 0.101 |
| LAD mid | 8 (17) | 16 (27) | 0.208 |
| LAD distal | 7 (15) | 17 (29) | 0.352 |
| Embolic events (stroke or TIA) | 8 (17) | 3 (0.5) | 0.048 |
Values are presented as mean±SD or number (%). PCI: percutaneous coronary intervention, CABG: coronary artery bypass graft, ACE: angiotensine converting enzyme, LV: left ventricle, ECG: electrocardiography, LAD: left anterior descending artery, TIA: transient ischemic attack
Biochemical and hematological characteristics of study subjects and controls
| Variables | Thrombus (+) patients (n=45) | Thrombus (−) patients (n=58) | p |
|---|---|---|---|
| Glucose (mg/dL±SD) | 141.36±73.53 | 139.22±48.43 | 0.837 |
| Creatinine (mg/dL±SD) | 1.31±1.49 | 1.09±0.67 | 0.210 |
| Sodium (mmol/dL±SD) | 138.47±3.37 | 138.64±1.29 | 0.480 |
| Potasium (mmol/dL±SD) | 4.43±0.63 | 4.52±0.53 | 0.464 |
| Total cholesterol (mg/dL±SD) | 171.53±44.82 | 186.41±53.44 | 0.622 |
| LDL cholesterol (mg/dL±SD) | 102.09±37.51 | 121.03±37.21 | 0.510 |
| HDL cholesterol (mg/dL±SD) | 38.09±10.80 | 54.77±25.67 | 0.180 |
| Triglyseride (mg/dL±SD) | 145.39±58.41 | 149.40±72.41 | 0.341 |
| Hemoglobine (g/L±SD) | 14.17±2.11 | 14.28±2.12 | 0.510 |
| Hematocrite (%±SD) | 42.34±4.92 | 42.52±3.32 | 0.349 |
| White blood cell (103/µL±SD) | 9.33±4.05 | 10.90±9.40 | 0.330 |
| Platelet (103/mm3±SD) | 230.04±55.59 | 254.15±52.46 | 0.724 |
| Glomeruler filtration rate (ml/min/1.73 m2±SD) | 49.5±4.5 | 58.6±2.3 | 0.124 |
| Neutrophil lymphocyte ratio (%±SD) | 3.84±1.6 | 2.85±1.6 | 0.003 |
| Platelet lymphocyte ratio (%±SD) | 131±64 | 130±62 | 0.508 |
Values are presented as mean±SD. LDL: low density lipoprotein cholesterol, HDL: high density lipoprotein cholesterol, SD: standard deviation
Multivariate regression analysis of confounding variables to predict apical thrombus
| Multivariate regression | ||
|---|---|---|
| β | p | |
| NLR | 0.296 | 0.024 |
| PLR | 0.092 | 0.530 |
| LVEF | 0.102 | 0.103 |
| LAD proximal lesion | 0.286 | 0.013 |
| ECG changes | 0.482 | <0.001 |
| Smoking | 0.305 | 0.012 |
| Age | 0.106 | 0.277 |
| DM | 0.217 | 0.076 |
| HT | 0.248 | 0.067 |
| HDL cholesterol | −0.086 | 0.847 |
| LDL cholesterol | 0.180 | 0.112 |
NLR: neutrophil lymphocyte ratio, PLR: platelet lymphocyte ratio, LVEF: left ventricle ejection fraction, LAD: left anterior descending artery, ECG: electrocardiography, DM: diabetes mellitus, HT: hypertension, LVEF: left ventricular ejection fraction
Fig. 1Sensitivity and specificity of neutrophil lymphocyte ratios for apical thrombus. ROC: receiver operating characteristic, AUC: area under curve, CI: confidence interval.